Herbas VPB

Print
EN | LT
LT - Chimeriniai adenovirusiniai vektoriai ir dsRNR, kaip TLR3 antagonistas
EN - Chimeric Adenoviral Vectors and dsRNA as TLR3 Agonist

Legal status

Patent lapsed (non-payment of fees)

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07H 21/00 (2006.01)
C07H 21/02 (2006.01)
C07H 21/04 (2006.01)
C12N 15/63 (2006.01)
A61K 48/00 (2006.01)
A61K 39/39 (2006.01)
European patent
(11) Number of the document 1996238
(13) Kind of document T
(96) European patent application number 07752109.4
Date of filing the European patent application 2007-02-28
(97) Date of publication of the European application 2008-12-03
(45) Date of publication and mention of the grant of the patent 2016-04-06
(46) Date of publication of the claims translation 2016-09-12
PCT application
(86) Number PCT/US2007/005386
Date 2007-02-28
PCT application publication
(87) Number WO 2007/100908
Date 2007-09-07
Priority applications
(30) Number Date Country code
778026 P 2006-02-28 US
801645 P 2006-05-19 US
802992 P 2006-05-22 US
821492 P 2006-08-04 US
846658 P 2006-09-22 US
848195 P 2006-09-28 US
Inventors
(72)
TUCKER, Sean, N., US
Grantee
(73) Vaxart, Inc., 600 Townsend Street Suite 120E, San Francisco, CA 94103, US
Attorney or representative
(74) Reda ŽABOLIENĖ, METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius, LT
Title
(54) Chimeriniai adenovirusiniai vektoriai ir dsRNR, kaip TLR3 antagonistas
  Chimeric Adenoviral Vectors and dsRNA as TLR3 Agonist
Last renewal fee
Payment date Validity (years) Amount
2020-01-31 14 289.00 EUR
Legal status
Patent lapsed (non-payment of fees)
Invalidation date 2021-02-28